Elicio Therapeutics, Inc. (ELTX)
USD 5.05
(-1.94%)
USD 5.05
(-1.94%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 28.31 Million | 2.88 Million | 1.48 Million | 4.02 Million |
| Cost of Revenue | 1.17 Million | 1.05 Million | 1.23 Million | 1.81 Million | 1.13 Million | 380 Thousand |
| Gross Profit | -1.17 Million | -1.05 Million | 27.07 Million | 1.06 Million | 351 Thousand | 3.64 Million |
| Operating Expenses | 34.57 Million | 23.73 Million | 25.47 Million | 15.72 Million | 12.34 Million | 17.99 Million |
| Selling, General and Administrative Expenses | 11.89 Million | 5.63 Million | 7.54 Million | 3 Million | 2.79 Million | 8.84 Million |
| Research and Development Expenses | 22.67 Million | 18.1 Million | 17.93 Million | 12.71 Million | 9.54 Million | 9.15 Million |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 35.74 Million | 23.73 Million | 25.47 Million | 15.72 Million | 12.34 Million | 18.37 Million |
| Operating Income | -35.74 Million | -23.73 Million | -25.47 Million | -15.72 Million | -12.34 Million | -14.34 Million |
| Interest Expense | 1.05 Million | 3.59 Million | 876.44 Thousand | - | - | - |
| Income Tax Expense | - | 3.59 Million | 876.44 Thousand | 8942.00 | 81.48 Thousand | - |
| Earnings before Tax | -35.19 Million | -28.2 Million | -26.4 Million | -15.71 Million | -12.26 Million | -20.02 Million |
| Net Income | -35.19 Million | -28.2 Million | -26.4 Million | -15.71 Million | -12.26 Million | -20.02 Million |
| Earnings Per Share Basic | -6.96 | -9.10 | -8.25 | -1.93 | -1.50 | -6.79 |
| Earnings Per Share Diluted | -6.96 | -9.10 | -8.25 | -1.93 | -1.50 | -6.79 |
| Weighted Average Shares Outstanding | 5.05 Million | 3.1 Million | 3.2 Million | 8.15 Million | 8.15 Million | 2.94 Million |
| Weighted Average Shares Outstanding (Diluted) | 5.05 Million | 3.1 Million | 3.2 Million | 8.15 Million | 8.15 Million | 2.94 Million |
| Gross Margin | - | - | 0.96 | 0.37 | 0.24 | 0.91 |
| EBIT Margin | - | - | -0.89 | -5.39 | -8.23 | -3.56 |
| Profit Margin | - | - | -0.93 | -5.46 | -8.25 | -4.97 |
| EBITDA | -32.96 Million | -23.55 Million | -51.92 Million | -15.52 Million | -40.16 Million | -14.34 Million |
| Earnings Before Tax Margin | - | - | -0.90 | -5.46 | -8.30 | -3.56 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 293 Thousand | 290 Thousand | 1.17 Million | 286 Thousand | - | - |
| Gross Profit | -293 Thousand | -290 Thousand | -1.17 Million | -286 Thousand | - | - |
| Operating Expenses | 10.63 Million | 10.24 Million | 34.57 Million | 9.39 Million | 10.77 Million | 7.77 Million |
| Selling, General and Administrative Expenses | 2.53 Million | 2.68 Million | - | 3.23 Million | 3.5 Million | 2.83 Million |
| Research and Development Expenses | 8.1 Million | 7.55 Million | - | 6.15 Million | 7.26 Million | 4.94 Million |
| Other Expenses | - | - | - | - | 113 Thousand | 218 Thousand |
| Cost and Expenses | 10.92 Million | 10.24 Million | 35.74 Million | 9.39 Million | 10.77 Million | 7.77 Million |
| Operating Income | -10.92 Million | -10.24 Million | -35.74 Million | -9.39 Million | -10.77 Million | -7.77 Million |
| Interest Expense | 49 Thousand | 36 Thousand | 1.05 Million | 2000.00 | 1000.00 | 714 Thousand |
| Income Tax Expense | - | 36 Thousand | - | 2000.00 | -273 Thousand | -501 Thousand |
| Earnings before Tax | -7.22 Million | -11.82 Million | -35.19 Million | -8.94 Million | -10.65 Million | -7.55 Million |
| Net Income | -7.22 Million | -11.82 Million | -35.19 Million | -8.94 Million | -10.65 Million | -7.55 Million |
| Earnings Per Share Basic | -0.64 | -1.15 | - | -0.93 | -1.27 | -2.44 |
| Earnings Per Share Diluted | -0.64 | -1.15 | - | -0.93 | -1.27 | -2.44 |
| Weighted Average Shares Outstanding | 11.28 Million | 10.27 Million | 5.05 Million | 9.6 Million | 8.37 Million | 3.1 Million |
| Weighted Average Shares Outstanding (Diluted) | 11.28 Million | 10.27 Million | 5.05 Million | 9.6 Million | 8.37 Million | 3.1 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -10.63 Million | -10.37 Million | - | -9.03 Million | -10.77 Million | -7.77 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
REKO
NPKYF
MARS
TKBP
ELRRF
OILFF